Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Memo to Congress: Don’t Cut Foreign Aid
06/15/2017. US spend less than 1 percent of the federal budget on foreign assistance.
OCHA launches its 2017 Plan and Budget
03/16/2017. 2017 is already a year of brutal conflict and escalating humanitarian crises.
Order of Malta and Red Cross united by a “red thread”: helping those who suffer
09/22/2018. “We are united by a ‘red thread’: we work toward the same ends, based on the principle of neutrality and prompted by the attempt to help people who suffer, without any discrimination,” said the Grand Master when greeting the guests.
